This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V4 | August 2025

Prescribing information and adverse event reporting statement can be found in the footer

This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V4 | August 2025

Prescribing information and adverse event reporting statement can be found in the footer

This educational and promotional event is organised and funded by Flynn Pharma Ltd. This meeting is intended for UK healthcare professionals.

Flynn Neurodevelopmental Study Day

Wednesday 25 February 2026
Join us for this NDD study day where we will discuss if there is a difference in sleep between ADHD and ASD, deep-dive into ADHD, and learn through group workshops. Guest speakers include Dr Folasade Johnson, Dr Imad Ahmed, Dr Caroline Bleakley, Dr Usha Roy, Emma Underwood and Dr Alice McCloskey.
An account is required to register for this event.

Event Details

In-person event details

Venue: Leonardo Hotel, East Midlands Airport, Ashby Road, Castle Donington, Derby DE74 2SH
Time: 09:00 -
15:30

Additional Information: Due to the expected popularity of this event early booking is advised. Physical spaces for this meeting are limited and will be allocated on a first come, first served basis.

Agenda

09:00
Registration, networking and refreshments,
09:25
Welcome and introduction, Dr Folasade Johnson, Consultant Community Paediatrician, Clinical Associate Professor in Medical Education, United Lincolnshire Hospitals NHS Trust
09:30
Sleep in ADHD and autism: Is there any difference? Dr Imad Ahmed, Consultant in Paediatric Respiratory and Sleep Medicine, University Hospitals of Leicester NHS Trust
10:30
Understanding ADHD in 2026, Dr Caroline Bleakley, Associate Specialist in Paediatric Neurodisability, Sheffield Children's NHS Foundation Trust
11:30
Break
11:45
ADHD and coexisting conditions, Dr Usha Roy, Consultant Paediatrician, Birmingham Community Healthcare NHS Foundation Trust
12:45
Lunch
13:45
Workshop 1: Neurodiversity and substance use, Emma Underwood, Young Person’s Clinical Nurse Specialist, Derby
Or
13:45
Workshop 2: Pill School – Improving access to optimised medicines, Dr Alice McCloskey, Associate Professor of Pharmacy, MPharm Programme Leader - Clinical Pharmacy and Therapeutics, Liverpool John Moores University
14:30
Workshop switchover
14:40
Workshop 1: Neurodiversity and substance use, Emma Underwood
Or
14:40
Workshop 2: Pill School – Improving access to optimised medicines, Dr Alice McCloskey
15:30
Meeting Close

Meet the Speakers

Dr Folasade Johnson
Dr Folasade Johnson
Consultant Community Paediatrician, Clinical Associate Professor in Medical Education, United Lincolnshire Hospitals NHS Trust

Dr Johnson is passionate about providing multidisciplinary diagnostic assessment and management to children and young people suspected of living with neurodisabilities. She has extensive clinical, teaching, managerial and research experience. She holds various roles in undergraduate and postgraduate medical education including, as a personal tutor, examiner, supervisor and Advance Clinical Phase Lead at the University of Nottingham.

Dr Johnson has a proven record of interpersonal and leadership skills coupled with achievements which span throughout her career. She has won clinical excellence awards and was recently nominated for the United Lincolnshire Hospitals NHS Trust Staff Awards in recognition for her hard work and dedication to patient care. Dr Johnson is also an author who enjoys travelling and contributing to her community.

Dr Imad Ahmed
Dr Imad Ahmed
Consultant in Paediatric Respiratory and Sleep Medicine, University Hospitals of Leicester NHS Trust

Dr Imad Ahmed is a consultant in Paediatric Respiratory and Sleep Medicine at University Hospitals of Leicester. His subspeciality interests include sleep medicine, long-term ventilation, and cystic fibrosis.

In addition to his clinical role, Dr Ahmed has a strong interest in medical leadership and service transformation. He is a board member of the International Paediatric Sleep Association (IPSA), co-chair of the Midlands Sleep Group and serves as the Children and Young People Clinical Lead at the Leicester, Leicestershire and Rutland Integrated Care Board.

His research interests focus on paediatric sleep apnoea, non-respiratory sleep disorders, and cardiopulmonary exercise testing in children. His main research areas include sleep diagnostics for children, sleep in neurodevelopmental disorders, and clinical outcomes in children on long-term ventilation.

Dr Caroline Bleakley
Dr Caroline Bleakley
Associate Specialist in Paediatric Neurodisability, Sheffield Children's NHS Foundation Trust

Dr Bleakley is a Neurodisability Paediatrician employed at Sheffield Children’s Hospital NHS Foundation Trust and serves as the Trust Lead for ADHD. With over 25 years of experience, she has developed a passionate and dedicated interest in supporting children, young people, and adults with ADHD, recognising it as a unique opportunity to change lives.

A strong advocate for “measurement-based care,” Dr Bleakley emphasises the importance of using structured outcome measures throughout the medical management and titration of ADHD medication, ensuring that individuals achieve a state of being “fully stable and optimised.”

Dr Bleakley is deeply interested in the evolving science of ADHD, particularly the connections between the brain and body, and is committed to bringing this science to life by sharing new insights and learning.

In addition to leading on ADHD, Dr Bleakley delivers tertiary clinics for holistic assessment, understanding, and management of children and young people with complex needs, including those with significant mental health, physical health challenges, or multiple coexisting conditions.

As a keen educator, Dr Bleakley also works with a large independent lifespan ADHD organisation as an external medical supervisor. Having benefited greatly from the mentorship of an inspirational Neurodisability Paediatrician, the founder of the Sheffield ADHD service, Dr Bleakley is dedicated to passing this learning forward and inspiring others in the same way.

Dr Usha Roy
Dr Usha Roy
Consultant Paediatrician, Birmingham Community Healthcare NHS Foundation Trust

Dr Roy is an Associate Specialist at Birmingham Community Healthcare NHS Foundation Trust, where she has worked for the past 20 years. Based in the north area of Birmingham, Dr Roy serves as the local lead for ADHD, an area of special professional interest.

She runs a weekly new and follow-up ADHD clinic and works closely with the dedicated ADHD nurse service to provide comprehensive assessment and ongoing care for individuals with ADHD.

Emma Underwood
Emma Underwood
Young Person’s Clinical Nurse Specialist, Derby

Emma is a Paediatric Nurse with over 20 years of experience across emergency and inpatient/community setting.

In 2023, she transitioned to a specialist role within substance misuse as a senior nurse, supporting young people under 18 who are affected by drug and alcohol use and gained her non-medical prescribing qualification.

Her work focuses on early intervention, education, and safeguarding. Emma has a special interest in neurodiversity and self-medication with illicit drugs. Her work is driven by a deep passion for making a positive impact and embracing the unique challenges and rewards of engaging with young people in meaningful, transformative ways.

Dr Alice McCloskey
Dr Alice McCloskey
Associate Professor of Pharmacy, MPharm Programme Leader - Clinical Pharmacy and Therapeutics, Liverpool John Moores University.

Dr McCloskey is a registered pharmacist of the GPhC and PSNI with a range of experience working across the three main sectors of pharmacy- clinical practice, academia and industry. Upon successful completion of her pre-registration training, Dr McCloskey returned to Queen's University Belfast and completed a PhD in pharmaceutics where she developed 'Self-assembled Peptide Nanomaterials for the Prevention of Biomaterial Infection.'

This was followed by an industry-academia collaborative post-doc between the Royal College of Surgeons in Ireland (RCSI, Dublin) and the Galway-based nebuliser company Aerogen, a global leader in aerosol delivery. This work was also linked with a national patient focused medical device research centre, CURAM based at The National University of Ireland, Galway. Dr McCloskey is a member of the Royal Pharmaceutical Society and Fellow of HEA (Higher Education Academy). Links are maintained with clinical pharmacy through regular days in practice both in hospital and community settings

What will the event cover?

Key learning objectives

  • To explore a range of approaches for the effective management of sleep difficulties in young people with neurodevelopmental disorders.
  • To provide an understanding of ADHD to better identify, manage, and advocate for individuals with ADHD across the lifespan.
  • To gain insights into the treatment of ADHD, including the management of common coexisting conditions.
  • To review best practices for addressing substance use, including drug and alcohol-related issues, in young people with neurodiversity.
  • To investigate the acceptability of swallowing tablets in children.